Primary relevance to vitamin D Vitamin D is a stated subject of this paper.
Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.
Why this paper is included
Supporting source evidence:
Serum 25(OH)D was significantly lower in PCOS women compared to fertile controls (mean 25(OH)D of 49.0 nmol/l versus 64.5 nmol/l).
Source: Abstract. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Cross-sectional study.
Cross-sectional study
Examines a population at a particular point in time.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study
Source: Article title.
Women were excluded if the blood draw was not performed in a fasting state.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study
Cross-sectional study · PLoS ONE · 2018
Original publication title
Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study
© 2018 Krul-Poel et al
Original publication · Publisher record · CC BY 4.0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What objectives does the paper state?
To compare vitamin D status in women with PCOS versus fertile women and subsequently evaluate the association between vitamin D status and metabolic disturbances in PCOS women.
Source: ObjectiveAbstract: What methods does the paper describe?
We conducted a cross-sectional comparison study of 639 women with PCOS and 449 fertile women. Serum 25-hydroxyvitamin D (25(OH)D) was stratified into a severe deficient (< 25 nmol/l), insufficient (25 to 50 nmol/l), moderate (50 to 75 nmol/l) and adequate (> 75 nmol/l) status. The main outcome measures were the difference in vitamin D status between PCOS and fertile women, and the association between serum 25(OH)D and metabolic disturbances in PCOS women only.
Source: MethodsAbstract: Results
Serum 25(OH)D was significantly lower in PCOS women compared to fertile controls (mean 25(OH)D of 49.0 nmol/l versus 64.5 nmol/l). An adjusted significant difference was seen between serum 25(OH)D and homeostasis model assessment (HOMA-IR) (β = 0.76; 95% CI: 0.63 to 0.91; p < 0.01), HDL-cholesterol (β = 0.20; 95% CI: 0.05 to 0.60, p < 0.01) and apolipoprotein A1 (β = 26.2; 95% CI: 7.5 to 45.0, p < 0.01) between the highest vitamin D group compared to the lowest vitamin D group.
Source: ResultsAbstract: Conclusions
This study demonstrates that women with PCOS have a significantly lower serum 25(OH)D compared to fertile controls. A compromised vitamin D status in PCOS women is associated with a higher HOMA-IR and an unfavourable lipid profile. Large randomized controlled trials are necessary to explore the causality of this linkage.
Source: ConclusionsAuthors’ abstract
Objective
To compare vitamin D status in women with PCOS versus fertile women and subsequently evaluate the association between vitamin D status and metabolic disturbances in PCOS women.
Methods
We conducted a cross-sectional comparison study of 639 women with PCOS and 449 fertile women. Serum 25-hydroxyvitamin D (25(OH)D) was stratified into a severe deficient (< 25 nmol/l), insufficient (25 to 50 nmol/l), moderate (50 to 75 nmol/l) and adequate (> 75 nmol/l) status. The main outcome measures were the difference in vitamin D status between PCOS and fertile women, and the association between serum 25(OH)D and metabolic disturbances in PCOS women only.
Results
Serum 25(OH)D was significantly lower in PCOS women compared to fertile controls (mean 25(OH)D of 49.0 nmol/l versus 64.5 nmol/l). An adjusted significant difference was seen between serum 25(OH)D and homeostasis model assessment (HOMA-IR) (β = 0.76; 95% CI: 0.63 to 0.91; p < 0.01), HDL-cholesterol (β = 0.20; 95% CI: 0.05 to 0.60, p < 0.01) and apolipoprotein A1 (β = 26.2; 95% CI: 7.5 to 45.0, p < 0.01) between the highest vitamin D group compared to the lowest vitamin D group.
Conclusions
This study demonstrates that women with PCOS have a significantly lower serum 25(OH)D compared to fertile controls. A compromised vitamin D status in PCOS women is associated with a higher HOMA-IR and an unfavourable lipid profile. Large randomized controlled trials are necessary to explore the causality of this linkage.
Publication and source details
Original title: Vitamin D and metabolic disturbances in polycystic ovary syndrome (PCOS): A cross-sectional study
Y. H. M. Krul-Poel; P. P. Koenders; R. P. Steegers-Theunissen; E. ten Boekel; M. M. ter Wee; Y. Louwers; P. Lips; J. S. E. Laven; S. Simsek
PLoS ONE · 2018
Competing Interests: JSE has received research grants from the following pharmaceutical companies (in alphabetical order): Ferring, Merck Serono, Merck Sharpe and Dome, Organon, Shering Plough and Serono. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-11T20:37:33.401153+00:00
DOI: 10.1371/journal.pone.0204748 · PMC6279035